BSN: Cardiovascular Research Technologies (CRT) 2013

Home

News

Calendar

Top 200 Orgs

Top Orgs by Specialty

People, Speakers

About Us

My Profile

How We Rank

What's My Rank?
      What's My Popularity Score?
      In My Orgs?
      In My Specialities?
      In My Geography?
      In My Age?

My Mentors, Collaborators,
Associates, Peers, Buddies

Keep Me Up To Date
Specialty, Keyword,
Geography

People Making News

Latest Research From
Meetings

Recent Postings

People of Consequence (74519)

1. Peter Kowey
Lankenau Hospital
2. Lawrence W. Bassett
University of California
3. Robert S Kerbel
University of Toronto
4. Yehuda Shoenfeld
Sheba Medical Center
5. Paul Weiss
Gala Biotech business unit of Cardinal Health

Orgs of Consequence (21210)

1. University of California
2. Harvard University
3. The Mayo Clinic
4. National Institutes of Health
5. University of California, San Francisco

Terms of Consequence

1. Cells
2. Cancer
3. Genetics
4. Molecular
5. Proteins

Cardiovascular Research Technologies (CRT) 2013

Washington, District of Columbia
http://www.crtmeeting.org/default.aspx

Cardiovascular Research Technologies (CRT) 2013 will take place from February 23 - 26, 2013 in Washington DC. This year’s conference will be the most comprehensive to date. CRT 2013 has many new and exciting features, including a new, cutting-edge Valve & Structural Heart track, in addition to its standard five subject areas -- Coronary, Endovascular, Science, Technology and Nurse & Tech. Also new this year will be the Essentials of Clinical Research course as well as more exciting hands-on workshops and simulations.

Schedule of Presentations:

Saturday, February 23, 2013
06:00:00	New Presentation
06:00:00	New Presentation
18:55:00	Valve Evening Symposium \| TAVR EVENING SYMPOSIUM: STARTING A TAVR PROGRAM IN YOUR INSTITUTION	Paul J. Corso, Augusto D. Pichard
19:00:00	Valve Evening Symposium \| Dinner and Case Presentations	Augusto D. Pichard, Ron Waksman
19:15:00	Valve Evening Symposium \| Aortic Stenosis: The Evolution of our Understanding of Pathophysiology and Therapeutic Modalities	Robert O. Bonow
19:30:00	Valve Evening Symposium \| Discussion	Joseph Bavaria, Augusto D. Pichard, E. Murat Tuzcu, Alec Vahanian, Ron Waksman, Robert O. Bonow
19:40:00	Valve Evening Symposium \| The Heart Team: How Does it Work for TAVR?	E. Murat Tuzcu
19:55:00	Valve Evening Symposium \| Discussion	Joseph Bavaria, Augusto D. Pichard, E. Murat Tuzcu, Alec Vahanian, Ron Waksman, Robert O. Bonow
20:05:00	Valve Evening Symposium \| How to Tailor the Optimal Treatment Modality for the Patient with AS	Joseph Bavaria
20:20:00	Valve Evening Symposium \| Discussion	Joseph Bavaria, Augusto D. Pichard, E. Murat Tuzcu, Alec Vahanian, Ron Waksman, Robert O. Bonow
20:30:00	Valve Evening Symposium \| Case in the Box	Augusto D. Pichard
20:45:00	Valve Evening Symposium \| Discussion	Joseph Bavaria, Augusto D. Pichard, E. Murat Tuzcu, Alec Vahanian, Ron Waksman, Robert O. Bonow
20:55:00	Valve Evening Symposium \| TAVR: The European experience	Alec Vahanian
21:10:00	Valve Evening Symposium \| Discussion	Joseph Bavaria, Augusto D. Pichard, E. Murat Tuzcu, Alec Vahanian, Ron Waksman, Robert O. Bonow
21:20:00	Valve Evening Symposium \| Adjourn
Sunday, February 24, 2013
03:45:00	CTO Forum \| The Status of Collagenase for the Treatment of CTO	Bradley H. Strauss
06:00:00	New Presentation
06:00:00	CTO Forum \| Patient Selection for CTO Recanalization: What Are the Appropriate Criteria?	Tarek Helmy
06:00:00	New Presentation
06:00:00	CTO Forum \| Complications of CTO PCI I: Ischemia - Predictors, Prevention and Management	William L. Lombardi
06:00:00	CTO Forum \| Step-by-Step Review of the Retrograde Approach: Making the Connection - Reverse CART and CART	Craig A. Thompson
06:00:00	Valve & Structural Heart Revolution I \| My Own Experience with Mitral Clips	Michael J. Mack
06:30:00	Valve & Structural Heart Revolution I \| Taped Case Demonstration: Mitral Clip Procedure
06:50:00	Valve & Structural Heart Revolution I \| Tips for a Successful Mitral Clip Procedure	Saibal Kar
07:10:00	Valve & Structural Heart Revolution I \| How Do I Treat Functional MR? The Surgeon’s Perspective	Steven F. Bolling
07:20:00	Valve & Structural Heart Revolution I \| Update on Maze Technique and Results
07:30:00	Valve & Structural Heart Revolution I \| Is Aortic Valve Repair Superior to Replacement?
07:40:00	Valve & Structural Heart Revolution I \| Panel Discussion: TBA	Niv Ad, Steven F. Bolling, Saibal Kar, Michael J. Mack, Ted Feldman
07:45:00	CTO Forum \| Introduction and Welcome to the CRT CTO Club: A New Beginning	Richard R. Heuser, Craig A. Thompson
07:55:00	Valve & Structural Heart Revolution I \| MITRAL VALVE REPAIR	Niv Ad, Steven A. Goldstein
07:55:00	CTO Forum \| CTO 101: SETTING THE STAGE	Richard R. Heuser, Craig A. Thompson
07:55:00	ACS & AMI Management \| ANTIPLATELET CONTROVERSY FOR ACS: HOW WILL THIS iMPACT OUR PRACTICE	David J. Cohen, Ron Waksman, Stephen Wiviott
08:00:00	CTO Forum \| Treating CTOs: Is There Enough Evidence-Based Data? Or do We Need Further Randomized Clinical Trials	Gerald S. Werner
08:00:00	Valve & Structural Heart Revolution I \| Functional Mitral Regurgitation: When to Repair – The Surgeon’s Perspective	Steven F. Bolling
08:00:00	ACS & AMI Management \| New Mechanisms and Pathogenesis of Acute Coronary Syndromes	Renu Virmani
08:10:00	CTO Forum \| Indication for CTO PCI: Clinical Rationale and Appropriateness	J. Aaron Grantham
08:10:00	Valve & Structural Heart Revolution I \| The Echocardiographic Subtleties and Hallmarks of Diagnosing Structural and Functional Mitral Regurgitation	Steven A. Goldstein
08:10:00	ACS & AMI Management \| Why the Third Generation Antiplatelet Agents Are Superior to First and Second Generation	Paul A. Gurbel
08:20:00	ACS & AMI Management \| What Is the Standard of Care for Antiplatelet Therapy in Europe?	Michael Joner
08:20:00	Valve & Structural Heart Revolution I \| Current Surgical Standards for Mitral Leaflet and Chordal Repair	Thierry Georges Mesana
08:30:00	ACS & AMI Management \| What Is the Standard of Care for Antiplatelet Therapy in the US?	Jeffrey S. Berger
08:30:00	Valve & Structural Heart Revolution I \| Functional Mitral Regurgitation: When to Repair – The Interventional Cardiologist’s Perspective	Ted Feldman
08:30:00	CTO Forum \| Reduced Radiation Exposure During CTO PCI by a	Gerald S. Werner
08:40:00	Valve & Structural Heart Revolution I \| Pathology of the Mitral Valve: What You Need to Know	Renu Virmani
08:40:00	ACS & AMI Management \| Cost Analysis: Is it Still Cost Effective to Use Prasugrel or Ticagrelor vs. Generic Clopidogrel?	David J. Cohen
08:40:00	CTO Forum \| Wire Snaring, Externalization and More	Patrick Whitlow
08:50:00	ACS & AMI Management \| The Big Antiplatelet Debate: Why I Prefer Prasugrel Over Ticagrelor	Stephen Wiviott
08:50:00	Valve & Structural Heart Revolution I \| The Spectrum of Evolving Mitral Repair Techniques
09:00:00	CTO Forum \| How to Build Your Own CTO PCI Program	Tarek Helmy
09:00:00	ACS & AMI Management \| The Big Antiplatelet Debate: Why I Prefer Ticagrelor Over Prasugrel	Paul A. Gurbel
09:00:00	Valve & Structural Heart Revolution I \| Degenerative MR - The Surgical Landscape: Volumes, Techniques, and Early and Late Outcomes	Michael J. Mack
09:10:00	ACS & AMI Management \| Lessons from TRANSLATE-ACS	Tracy Wang
09:10:00	Valve & Structural Heart Revolution I \| MitraClip Results in Low and High Risk Degenerative MR: Emerging Data and Integrated Recommendations	Peter C. Block
09:10:00	CTO Forum \| Live Case Demonstration from Cannizzaro Hospital, Catania, Italy	Alfredo R. Galassi, Barry D. Rutherford, Jacques J. Koolen
09:20:00	Valve & Structural Heart Revolution I \| Percutaneous Approach to Mitral Valve Repair: Edge-to-Edge Mitral Leaflet Repair with the MitraClip--Technique Overview and a Taped Case	Saibal Kar
09:20:00	ACS & AMI Management \| How to Switch from Clopidogrel to Prasugrel or Ticagrelor
09:30:00	ACS & AMI Management \| Lessons from TRILOGY	Stephen Wiviott
09:30:00	Valve & Structural Heart Revolution I \| Know the Potential Uses and Limitations of the Mitral Clip
09:40:00	ACS & AMI Management \| Do We Need Prasugrel or Ticagrelor Beyond 30 Days?	David J. Cohen
09:40:00	Valve & Structural Heart Revolution I \| Percutaneous Approach to Mitral Valve Repair: Mitral Valve Replacement Technology Update	Howard C. Herrmann
09:50:00	Valve & Structural Heart Revolution I \| Direct Annuloplasty with Mitralign: Device Evolution, Technique and Clinical Trial Update
09:50:00	ACS & AMI Management \| PAR-1 Inhibitors: What Will Be the Role of Vorapaxar for the Treatment of ACS?	David J. Moliterno
10:00:00	Break
10:00:00	Valve & Structural Heart Revolution I \| Panel Discussion: Is Percutaneous Valve Repair Ready for Prime Time? For Whom?	Peter C. Block, Steven F. Bolling, Steven A. Goldstein, Howard C. Herrmann, Saibal Kar, Michael J. Mack, Renu Virmani, Ted Feldman, Thierry Georges Mesana
10:00:00	ACS & AMI Management \| Panel Discussion: Selection and Duration of Antiplatelet Therapy for Patients with ACS and AMI in 2013	David J. Cohen, C. Michael Gibson, Neal Kleiman, Ron Waksman, Stephen Wiviott, Steven R. Steinhubl
10:05:00	CTO Forum \| CTO COLLEGE: GETTING STARTED	Craig A. Thompson, Gerald S. Werner
10:10:00	CTO Forum \| Guiding Catheter Support Augmentation: Balloon Anchoring Techniques and Guidelines	William L. Lombardi
10:15:00	Valve & Structural Heart Revolution I \| Break
10:15:00	ACS & AMI Management \| Break
10:20:00	CTO Forum \| Anatomy of Contemporary CTO Guidewires and Selection Criteria	Patrick Whitlow
10:25:00	Valve & Structural Heart Revolution I \| MORE MITRAL VALVE INTERVENTIONS	Peter C. Block, Balram Bhargava
10:25:00	ACS & AMI Management \| ANTIPLATELET RESPONSIVENESS, GENETICS GENOMICS AND DRUG TO DRUG INTERACTIONS	Neal Kleiman, Paul A. Gurbel
10:30:00	CTO Forum \| Trends in Initial Guidewire Selection: For Antegrade and Retrograde Approach	J. Aaron Grantham
10:30:00	Valve & Structural Heart Revolution I \| Percutaneous Mitral Valve Complications and Bailout	Peter C. Block
10:30:00	ACS & AMI Management \| Does the Present Data Support Routine Platelet Responsiveness Testing?	George Dangas
10:40:00	CTO Forum \| Fundamentals of Wire Control and Evolution of the CTO Crossing Concept in Antegrade	Gerald S. Werner
10:40:00	Valve & Structural Heart Revolution I \| Dynamic Mitral Valve Ring Annuloplasty: The MiCardia Concept Clinical Update	Maurice Buchbinder
10:40:00	ACS & AMI Management \| Fibrinogen: Better Predictor of Ischemic Risk Than Platelet Reactivity?	Ehtisham Mahmud
10:50:00	ACS & AMI Management \| The Diabetic Patient and the Optimal Antiplatelet Therapy	Dominick J. Angiolillo
10:50:00	Valve & Structural Heart Revolution I \| Percutaneous Mitral Repair in High Surgical Risk Patients
11:00:00	ACS & AMI Management \| Genotyping: Which One Should We Perform, How to Interpret the Data and Is It Ready for Clinical Practice?	Alan R Shuldiner
11:00:00	CTO Forum \| Trends in Guidewire Selection in Refractory Cases	Craig A. Thompson
11:00:00	Valve & Structural Heart Revolution I \| Panel Discussion: What Should Be the Optimal Approach for Mitral Valve Repair - Minimally Invasive or Median Sternotomy Percutaneous Approach?	Peter C. Block, Hans R. Figulla
11:05:00	ACS & AMI Management \| DEBATE: TAILORING ANITPLATELET THERAPY
11:10:00	ACS & AMI Management \| We Should Tailor Antiplatelet Therapy Based on Platelet Function Testing and Genotyping	Paul A. Gurbel
11:10:00	CTO Forum \| Planning the Retrograde Attack: When to Switch to Retrograde-Predictors of Success vs. Failure	William L. Lombardi
11:15:00	Valve & Structural Heart Revolution I \| Clinical Experience with Percutaneous Mitral Repair	Peter C. Block
11:20:00	CTO Forum \| Selection of Collateral Channel
11:20:00	ACS & AMI Management \| There Is No Role for Platelet Function and Genomic Testing with the New Antiplatelet Agents	Neal Kleiman
11:25:00	Valve & Structural Heart Revolution I \| Transcatheter Approaches to Prosthetic Mitral Valve Failure and Paravalvular Leaks: Tips and Tricks
11:30:00	Valve & Structural Heart Revolution I \| MITRAL STENOSIS: FROM ASSESSMENT TO TREATMENT
11:30:00	CTO Forum \| Contrast Awareness: Strategies to Prevent Contrast Nephropathy	Roxana Mehran
11:30:00	ACS & AMI Management \| Panel Discussion: TBA
11:35:00	Valve & Structural Heart Revolution I \| Echocardiography of Mitral Stenosis: Severity and Important Echo Features	Steven A Goldstein
11:40:00	ACS & AMI Management \| THE ORAL FACTOR Xa INHIBITOR CONTROVERSY	C. Michael Gibson, Manesh R. Patel
11:40:00	CTO Forum \| Case Presentation III	Gerald S. Werner
11:40:00	Valve & Structural Heart Revolution I \| Timing of Intervention in Mitral Stenosis	Ted Feldman
11:45:00	ACS & AMI Management \| Did the Results of the RELY Trial Translate to Clinical Practice?	C. Michael Gibson
11:50:00	Valve & Structural Heart Revolution I \| How to Perform Balloon Mitral Valvuloplasty	Augusto D. Pichard
11:55:00	ACS & AMI Management \| Rivaroxaban in Patients with ST-Elevation Myocardial Infarction: Results from ATLAS ACS 2-TIMI 51	Manesh R. Patel
11:55:00	Valve & Structural Heart Revolution I \| New Surgical Aspects of MVR	Thierry Georges Mesana
11:55:00	CTO Forum \| Case Presentation IV	Jacques J. Koolen
12:05:00	ACS & AMI Management \| How to Combine Antiplatelet Therapy with Oral Factor Xa Inhibitor	Dominick J. Angiolillo
12:10:00	CTO Forum \| Lunch and Visit the Exhibits and Simulators
12:10:00	Valve & Structural Heart Revolution I \| Lunch and Visit the Exhibits and Simulators
12:15:00	ACS & AMI Management \| Lessons from the ARISTOTLE Trial	C. Michael Gibson
12:25:00	ACS & AMI Management \| RUBY-1: What Is in the Future for Oral Factor Xa Inhibition in ACS?	Sanjit S. Jolly
12:35:00	ACS & AMI Management \| Panel Discussion: How to Choose Your Oral Factor Xa Inhibitor	Dominick J. Angiolillo, C. Michael Gibson, Neal Kleiman, Manesh R. Patel, David J. Moliterno, Sanjit S. Jolly
12:50:00	ACS & AMI Management \| Lunch and Visit the Exhibits and Simulators
12:55:00	Valve & Structural Heart Revolution I \| AORTIC STENOSIS	Augusto D. Pichard, Michael J Reardon
13:00:00	Valve & Structural Heart Revolution I \| The Pathological Insight from Explanted Percutaneous Heart Valves: What Do You Need to Know Before TAVR?	Renu Virmani
13:05:00	CTO Forum \| CTO MASTERS: TAKING ALL COMERS	Barry D. Rutherford, Jacques J. Koolen
13:10:00	Valve & Structural Heart Revolution I \| Dynamics in Patient Selection from Inoperable to Moderate Risk: TAVR vs. SAVR	Alec Vahanian
13:10:00	CTO Forum \| Guidewire Externalization	J. Aaron Grantham
13:20:00	CTO Forum \| LAST (Limited Antegrade Subintimal Tracking): From Knuckle Wires to BridgePoint	Craig A. Thompson
13:20:00	Valve & Structural Heart Revolution I \| TAVR or Surgery for Low Flow AS: Insights From the PARTNER Trial	Howard C. Herrmann
13:30:00	CTO Forum \| The Radial Approach for CTO PCI: Utility in the Retrograde and the Antegrade Approaches	Shigeru Saito
13:30:00	Valve & Structural Heart Revolution I \| How TVAR Impacts Cardiac Surgery and What the Credentials for the Surgeon Should Be
13:35:00	ACS & AMI Management \| ACUTE MI MANAGEMENT	Eric R. Bates, Alice K. Jacobs, Jonathan S. Reiner, Lowell F. Satler
13:40:00	CTO Forum \| Case Presentation: Retorgrade Approach	Jacques J. Koolen
13:40:00	Valve & Structural Heart Revolution I \| The Heart Valve Team: The US Experience	Michael J Reardon
13:40:00	ACS & AMI Management \| How to Minimize Bleeding in STEMI Patients	Steven V. Manoukian
13:50:00	ACS & AMI Management \| Medical Therapy for STEMI Patients During Interhospital Transport: Fibrinolytic and/or Anticoagulant?	Eric R. Bates
13:50:00	Valve & Structural Heart Revolution I \| Are We Ready to Perform TAVR in Intermediate Risk Patients?
14:00:00	ACS & AMI Management \| Transradial Access for ACS, Primary PCI and Anticoagulation Considerations	Daniel H. Steinberg
14:00:00	Valve & Structural Heart Revolution I \| Panel Discussion: Who Should Be a Candidate for TAVR in 2013?	Howard C. Herrmann, Michael J Reardon, Alec Vahanian, Renu Virmani
14:00:00	CTO Forum \| Trends in CTO PCI in Europe: Update from the Euro CTO Club	Gerald S. Werner
14:05:00	Valve & Structural Heart Revolution I \| TRANSCATHETER AORTIC VALVE REPLACEMENT SHOW ME THE DATA	E. Murat Tuzcu, Alec Vahanian
14:10:00	Valve & Structural Heart Revolution I \| New Data from PARTNER	E. Murat Tuzcu
14:10:00	ACS & AMI Management \| New Insights into the Mortality Benefit of Bivalirudin	Gregg W. Stone
14:10:00	CTO Forum \| Evolution of Strategy for the CTO PCI in the United States and Canada: An Update on Hybrid CTO PCI	Richard R. Heuser
14:20:00	Valve & Structural Heart Revolution I \| New Data from the French Registry	Alec Vahanian
14:20:00	ACS & AMI Management \| Primary PCI Update from NCDR and the Action Registry	Manesh R. Patel
14:30:00	Valve & Structural Heart Revolution I \| Bern-Rotterdam-Munich Propensity Analysis: SVR vs. TAVR in >4000 Patients	Lutz Buellesfeld
14:30:00	ACS & AMI Management \| STEMI Systems of Care - Update on Mission: We Are Better, Are the Patients as Well?	Alice K. Jacobs
14:40:00	Valve & Structural Heart Revolution I \| What Does the Future Hold for the Transapical Approach?	Michael J. Mack
14:40:00	CTO Forum \| Complications of CTO PCI III: Complications Unique to the Retrograde Approach
14:40:00	ACS & AMI Management \| Integrating the EMS with Hospital Primary PCI Programs: Update on the Washington DC Experience	Jonathan S. Reiner
14:50:00	ACS & AMI Management \| Door-In, Door-Out: Why the Delay?
14:50:00	CTO Forum \| Break
14:50:00	Valve & Structural Heart Revolution I \| Review of the Latest OUS Data from the CoreValve Studies
15:00:00	ACS & AMI Management \| Telemedicine to Expedite Patients’ Transfer: The Cell Phone Experience	Lowell F. Satler
15:00:00	Valve & Structural Heart Revolution I \| Review of the Transaortic and Subclavian Approaches	Michael J Reardon
15:00:00	CTO Forum \| INNOVATION: WHAT'S NEXT?	Richard R. Heuser, Gerald S. Werner
15:05:00	CTO Forum \| Newer Methods to Facilitate the Retrograde Approach	Barry D. Rutherford
15:10:00	Valve & Structural Heart Revolution I \| The TAVR Valve-in-Valve Technique: Fundamentals and Clinical Results
15:10:00	ACS & AMI Management \| Telemedicine to Analyze ST Segment to Detect Events Post MI	C. Michael Gibson
15:15:00	CTO Forum \| The Value of Multislice CT and Co-Registration for Planning and Guidance of CTO-PCI
15:20:00	Valve & Structural Heart Revolution I \| Break
15:20:00	ACS & AMI Management \| Panel Discussion: How Should We Optimize Door-to-Balloon Time for STEMI in 2013?	Alice K. Jacobs, Manesh R. Patel, Jonathan S. Reiner, Lowell F. Satler, Gregg W. Stone, C. Michael Gibson
15:25:00	CTO Forum \| Applications for Intravascular Ultrasound in Chronic Total Occlusions	Barry D. Rutherford
15:30:00	Valve & Structural Heart Revolution I \| UTILIZING IMAGING TECHNIQUES TO OPTIMIZE TAVI RESULTS	Jeffrey J. Popma, Ron Waksman
15:35:00	CTO Forum \| OCT Guidance for CTO Avinger	Richard R. Heuser
15:35:00	ACS & AMI Management \| Break
15:35:00	Valve & Structural Heart Revolution I \| Optimal Techniques to Determine Valve Annulus Size	Raoul Bonan
15:45:00	Valve & Structural Heart Revolution I \| Best Techniques for Valve Positioning and Deployment
15:45:00	ACS & AMI Management \| THROMBUS MANAGEMENT IN THE CATH LAB	Steven V. Manoukian
15:50:00	ACS & AMI Management \| INFUSE AMI: Lessons from a Mid-Sized Randomized Study	Gregg W. Stone
15:55:00	CTO Forum \| Most Advanced Subintimal and Re-Entry Technique Using BridgePoint Devices: Lessons from Complex Cases	William L. Lombardi
15:55:00	Valve & Structural Heart Revolution I \| Imaging and Quantification of Aortic Regurgitation after TAVI	Lutz Buellesfeld
16:00:00	ACS & AMI Management \| Thrombus Management in the Cath Lab: What are the Options and Outcomes?	Sanjit S. Jolly
16:05:00	Valve & Structural Heart Revolution I \| Echo Monitoring: Complications During Transcatheter Intervention for Structural Heart Disease	Zuyue Wang
16:05:00	CTO Forum \| Adjuvant Medical Therapy for Incomplete Revascularization	Giora Weisz
16:05:00	ACS & AMI Management \| MYOCARDIAL PRESERVATION AND RESTORATION	Steven V. Manoukian
16:10:00	ACS & AMI Management \| Translational Research for Myocardial Regeneration
16:15:00	Valve & Structural Heart Revolution I \| Is Transesophageal Echo During TAVR Essential?	Alec Vahanian
16:15:00	CTO Forum \| Tips and Tricks for Difficult Scenarios: Long CTO, Heavily Calcified, LM Bifurcation	Gerald S. Werner
16:20:00	ACS & AMI Management \| Use of FFR/OCT in ACS & AMI	Giulio Guagliumi
16:25:00	Valve & Structural Heart Revolution I \| Taped Case Demonstration: The Balloon- Expanding Transcatheter Valve System	E. Murat Tuzcu
16:25:00	CTO Forum \| Live Case Demonstration from Kusatsu Heart Center, Kusatsu, Japan
16:30:00	ACS & AMI Management \| How to Optimize Therapeutic Hypothermia and What to Expect	Michael R. Mooney
16:40:00	ACS & AMI Management \| The Use of Impella for Cardiogenic Shock Patients: Does it Save Lives?
16:45:00	Valve & Structural Heart Revolution I \| Taped Case Demonstration: The Self- Expanding Transcatheter Valve System
16:50:00	ACS & AMI Management \| IABP-SHOCK II: Randomized Comparison of Intra-Aortic Balloon Counterpulsation vs. Optimal Medical Therapy in Addition to Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock	Manesh R. Patel
17:00:00	ACS & AMI Management \| Adjourn
17:05:00	Valve & Structural Heart Revolution I \| Panel Discussion: What Imaging Is Required During TAVR?	Raoul Bonan, E. Murat Tuzcu, Alec Vahanian, Zuyue Wang, Lutz Buellesfeld
17:20:00	Valve & Structural Heart Revolution I \| Adjourn
17:35:00	CTO Forum \| Adjourn	J. Aaron Grantham
18:25:00	Valve & Structural Heart Revolution I \| VALVE & STRUCTURAL HEART REVOLUTION FOR THE SURGEON BREAKFAST I	Steven F. Bolling, Niv Ad
Monday, February 25, 2013
06:25:00	Complex Coronary Interventions I \| BASIC RADIAL ACCESS	Ramon Quesada
06:30:00	Complex Coronary Interventions I \| Breakfast
06:45:00	Complex Coronary Interventions I \| Getting Radial Access LT and RT	Saibal Kar
07:00:00	Complex Coronary Interventions I \| Catheter Selection for Coronary Angiography
07:10:00	Complex Coronary Interventions I \| How to Become a Superb Radialist	Sunil V. Rao
07:20:00	Complex Coronary Interventions I \| Anticoagulant Choices in Transradial PCI in ACS	Daniel H. Steinberg
07:35:00	Complex Coronary Interventions I \| Hemostasis & Radial Artery Occlusion	Ramon Quesada
07:45:00	Complex Coronary Interventions I \| Case Reviews	Shigeru Saito
12:15:00	Complex Coronary Interventions I \| LUNCHEON SYMPOSIUM: CHANGING THE LANDSCAPE OF INTERVENTION IN THE US	Jeffrey J. Popma, Ron Waksman
12:20:00	Complex Coronary Interventions I \| Lunch
12:45:00	Complex Coronary Interventions I \| Does Second Generation DES Require A Shorter Duration of DAPT?	Laura Mauri
12:55:00	Complex Coronary Interventions I \| Expanding TAVR Beyond High Risk and Inoperable Patients	Jeffrey J. Popma
13:05:00	Complex Coronary Interventions I \| Renal Denervation Beyond Treatment of Hypertension	Felix Mahfoud
13:15:00	Complex Coronary Interventions I \| Drug Coated Balloons for Peripheral Artery Disease	MICHAEL R. JAFF
13:25:00	Complex Coronary Interventions I \| Panel Discussion	David E. Kandzari, Jeffrey J. Popma, Ron Waksman, MICHAEL R. JAFF, Felix Mahfoud
13:55:00	Complex Coronary Interventions I \| THE iMPACT TRIALS: SESSION I	Maurice Buchbinder, Ron Waksman, William Fearon, Ian T. Meredith
14:00:00	Complex Coronary Interventions I \| iMPACT Trial I
14:10:00	Complex Coronary Interventions I \| iMPACT Trial II
14:20:00	Complex Coronary Interventions I \| Commentary on the iMPACT Trials Session I	Laura Mauri
14:30:00	Complex Coronary Interventions I \| Live Case Demonstration from MedStar Washington Hospital Center, Washington, DC	Kenneth M. Kent, Augusto D. Pichard, Lowell F. Satler
15:15:00	Complex Coronary Interventions I \| Keynote Lecture: The Five Best Trials from 2012 that May iMPACT My Practice	Gregg W. Stone
15:25:00	Complex Coronary Interventions I \| Keynote Lecture What Does the Future Hold for Appropriateness, Guidelines, Reimbursement and Credentialing?	David R. Holmes
15:35:00	Complex Coronary Interventions I \| FFR, IVUS and OCT: Which Should We Use and When?	Gary S. Mintz
15:45:00	Complex Coronary Interventions I \| Lessons from FAME II and Review of the Results	William Fearon
15:55:00	Complex Coronary Interventions I \| Medical Therapy Should Work Well for Patients with Documented Ischemia	William E. Boden
16:05:00	Complex Coronary Interventions I \| The Future Is Medical Therapy: The Pipeline Is Robust	Steven E Nissen
16:15:00	Complex Coronary Interventions I \| Panel Discussion: How the COURAGE, FAME II and ISCHEMIA Trials Will Change Our Practice	Gary S. Mintz, Steven E Nissen, William E Boden, William Fearon
16:30:00	Complex Coronary Interventions I \| Live Case Demonstration from MedStar Washington Hospital Center, Washington, DC
17:15:00	Complex Coronary Interventions I \| Adjourn
Tuesday, February 26, 2013
06:25:00	Complex Coronary Interventions II \| ADVANCED RADIAL ACCESS	Ramon Quesada
06:30:00	Complex Coronary Interventions II \| Breakfast
06:45:00	Complex Coronary Interventions II \| Transradial Peripheral Intervention
06:55:00	Complex Coronary Interventions II \| Transradial Primary PCI	Daniel H. Steinberg
07:05:00	Complex Coronary Interventions II \| Transradial in Women	Sunil V. Rao
07:25:00	Complex Coronary Interventions II \| Treating CTO via Radial?	Richard R. Heuser
07:35:00	Complex Coronary Interventions II \| The Economics of Transradial Access
07:45:00	Complex Coronary Interventions II \| Case Reviews	Ramon Quesada
07:55:00	Complex Coronary Interventions II \| COMPLEX CORONARY INTERVENTIONS	Spencer B. King III, Ron Waksman
08:00:00	Complex Coronary Interventions II \| Live Case Demonstration from MedStar Washington Hospital Center, Washington, DC	Kenneth M. Kent, Augusto D. Pichard, Lowell F. Satler
08:30:00	Complex Coronary Interventions II \| After FREEDOM and SYNTAX: Can PCI Be an Alternative to Surgery in Patients with Multivessel Disease?	Spencer B. King
08:45:00	Complex Coronary Interventions II \| Live Case Demonstration from Brussels University Hospital Brussels, Belgium	Danny Schoors, Jacques J. Koolen
09:30:00	Complex Coronary Interventions II \| How to Select Your DES: The Data-Driven Clinician’s View	David A. Cox
09:40:00	Complex Coronary Interventions II \| Optimal Duration of DAPT: Did We Go Too Far?	Laura Mauri
09:45:00	Complex Coronary Interventions II \| COMPLEX CORONARY INTERVENTIONS: COMPLEX LESION SUBSETS	Jeffrey W. Moses
09:50:00	Complex Coronary Interventions II \| Keynote Lecture: Unprotected Left Main: Pearls of Wisdom for Success	Jeffrey W. Moses
10:00:00	Complex Coronary Interventions II \| Bifurcation Management Update: Choosing the Right Strategy and Technique
10:10:00	Complex Coronary Interventions II \| ISAR-LEFT MAIN 2: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents in Patients with Unprotected Left Main Disease	Adnan Kastrati
10:20:00	Complex Coronary Interventions II \| Panel Discussion: Is there Enough Data to Support Routine PCI for Unprotected Left Main	Adnan Kastrati, Jeffrey W. Moses
10:25:00	Complex Coronary Interventions II \| BRAZIL @ CRT	Alexandre Abizaid, Jeffrey W. Moses
10:30:00	Complex Coronary Interventions II \| Live Case Demonstration from Morristown Medical Center, Morristown, NJ	Maurice Buchbinder, Curtiss T. Stinis
11:30:00	Complex Coronary Interventions II \| Late-Breaking Clinical Trials and Technology from South America	Alexandre Abizaid
11:40:00	Complex Coronary Interventions II \| Review of Structural Heart Programs in Brazil
11:50:00	Complex Coronary Interventions II \| How to Perform Successful PCI in SVG Lesions	John S. Douglas
11:55:00	Complex Coronary Interventions II \| IMPACT TRIALS – SESSION II	Michael J. Cowley, Adnan Kastrati
12:00:00	Complex Coronary Interventions II \| iMPACT Trial III
12:10:00	Complex Coronary Interventions II \| iMPACT Trial IV
12:20:00	Complex Coronary Interventions II \| Commentary on iMPACT Trials: Session II	Adnan Kastrati
12:30:00	Complex Coronary Interventions II \| Lunch and Visit the Exhibits and Simulators
14:00:00	Complex Coronary Interventions II \| Live Case Demonstration from Mount Sinai Medical Center, New York, NY	Samin K. Sharma
14:55:00	Complex Coronary Interventions II \| PROCEDURES TO iMPACT YOUR PRACTICE	David A. Cox, Augusto D. Pichard
15:00:00	Complex Coronary Interventions II \| How to Perform a Safe Transseptal	Augusto D. Pichard
15:10:00	Complex Coronary Interventions II \| Essentials for CTO Recanalization	Richard R. Heuser
15:20:00	Complex Coronary Interventions II \| How to Convert Your Access to the Radial Approach	Ramon Quesada
15:30:00	Complex Coronary Interventions II \| Alcohol Septal Ablations	Kenneth M. Kent
15:40:00	Complex Coronary Interventions II \| Thrombus Management and No Reflow in the Cath Lab: Tools and Tips
15:50:00	Complex Coronary Interventions II \| Cath Lab Nightmare: How to Avoid the Worst Complication	John S. Douglas
16:00:00	Complex Coronary Interventions II \| How to Handle a Complex Bifurcation Lesion	Curtiss T. Stinis
16:10:00	Complex Coronary Interventions II \| A Critical Evaluation of Bifurcation Trials & the State of our Knowledge
16:15:00	Complex Coronary Interventions II \| INTERESTING CASE PRESENTATIONS	Rajiv Gulati, Jay Giri
16:20:00	Complex Coronary Interventions II \| Interesting Case Presentation
16:30:00	Complex Coronary Interventions II \| Interesting Case Presentation
16:40:00	Complex Coronary Interventions II \| Interesting Case Presentation
16:50:00	Complex Coronary Interventions II \| CRT 2013 Closing Remarks	Augusto D. Pichard
17:00:00	Complex Coronary Interventions II \| Adjourn

BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.